Skip to content
The Policy VaultThe Policy Vault

tazaroteneUnited Healthcare

plaque psoriasis

Preferred products

  • topical corticosteroid (e.g., clobetasol, halobetasol)

Initial criteria

  • Diagnosis of plaque psoriasis
  • History of failure, contraindication, or intolerance to a topical corticosteroid (e.g., clobetasol, halobetasol)

Reauthorization criteria

  • Documentation of positive clinical response to therapy

Approval duration

12 months